Poster Session 4
Category: Perinatal Mental Health
Poster Session 4
Samantha P. Gottlieb, BS (she/her/hers)
Clinical Research Coordinator
Ann & Robert H. Lurie Children's Hospital of Chicago
Lurie Children's Hospital, Chicago, IL, Illinois, United States
Sarah L. Kaplan, BA (she/her/hers)
Ann & Robert H. Lurie Children's Hospital of Chicago
Atlanta, Georgia, United States
Frances Kincaid, BS, MS
Northwestern University
Northwestern University, Illinois, United States
Estefania Espinosa, BS
Northwestern University
Chicago, Illinois, United States
Kennedi Williams, BA
Research Study Assistant
Northwestern University
Chicago, Illinois, United States
Jiafeng Li, MS
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Madeline R. Meirhaeghe, BS
Ann & Robert H. Lurie Children's Hospital of Chicago
LIncolnshire, Illinois, United States
Abigail L. Aron, BA
Ann & Robert H. Lurie Children's Hospital of Chicago
Ann & Robert H. Lurie Children's Hospital of Chicago, Illinois, United States
Mary Akel, MPH
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Tonia Branche, BA, MD, MPH
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Leena B. Mithal, MD, MSCI
Associate Professor
Ann & Robert H. Lurie Children’s Hospital; Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
Stephanie A. Fisher, MD, MPH (she/her/hers)
Assistant Professor of Obstetrics and Gynecology
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
To evaluate the association of antenatal psychosocial stressors with inflammatory biomarkers in pregnancy.
Study Design:
Secondary analysis of data from the prospective Chicago Perinatal Origins of Disease (CPOD) cohort of pregnant people with singleton gestations at a large academic center. Exposures were participant scores on the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) at 8-24 weeks (Table 1), and the Perceived Stress Scale (PSS-10) and the Everyday Discrimination Scale (EDS) at 18-36 weeks (Table 2), completed via electronic survey. Outcomes were log-transformed concentrations of plasma inflammatory cytokines (IL1β, IL2, IL6, IL8, IL10, IFNγ, TNFα) and cytokine-induced cell adhesion molecules (ICAM1, VCAM1), measured via Meso Scale Discovery immunoassay. Student’s t-tests compared mean differences in biomarker concentrations, and linear regression models generated beta (ß)-coefficients adjusted for pre-pregnancy body mass index.
Results:
Of 118 enrolled participants, 99 completed the above psychosocial stress screeners and provided a plasma sample, with 22% and 26% identifying as Black or Hispanic, respectively. Median gestational age at plasma sample collection was 28.7 weeks’ gestation (IQR 26.1, 32.4). PHQ-9 (mean difference 0.73 pg/mL; p-value 0.02) and GAD-7 scores ≥5 (mean difference 0.64 pg/mL; p-value 0.03), indicating at least mild depressive and/or anxiety symptoms, were associated with higher IL6 concentrations, and a PHQ-9 score ≥5 (vs. < 5) was associated with higher ICAM1 concentrations. When assessed as continuous measures, higher PSS scores were associated with lower IL1ß (adj. ß -0.57; 95% CI -0.03, -1.12) and IL10 (adj. ß -0.52; 95% CI -0.05, -0.98). Higher EDS scores were associated with lower IFNγ (adj. ß -0.031; 95% CI -0.01, -0.05).
Conclusion:
In the CPOD cohort, anxiety and depressive symptoms were positively associated with the pro-inflammatory IL6, while greater perceived stress and discrimination in pregnancy were associated with suppression of anti-inflammatory IL10 and IFNγ, a regulator of anti-inflammatory processes.